Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injectionsVisa övriga samt affilieringar
2022 (Engelska)Ingår i: Journal of diabetes and its complications, ISSN 1056-8727, E-ISSN 1873-460X, Vol. 36, nr 3, artikel-id 108110Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
In this post-hoc analysis of data from a randomised clinical trial, we compared the effect of liraglutide to placebo on markers of insulin secretion in persons with type 2 diabetes treated with multiple daily insulin injections. Liraglutide increased insulin secretion, measured by C-peptide, by 19% after 24 weeks of treatment.
Ort, förlag, år, upplaga, sidor
ELSEVIER SCIENCE INC , 2022. Vol. 36, nr 3, artikel-id 108110
Nyckelord [en]
Type 2 diabetes mellitus; GLP-1 analogues; Multiple daily insulin injections; Insulin secretion
Nationell ämneskategori
Endokrinologi och diabetes
Identifikatorer
URN: urn:nbn:se:liu:diva-183751DOI: 10.1016/j.jdiacomp.2021.108110ISI: 000759752600006PubMedID: 35101325OAI: oai:DiVA.org:liu-183751DiVA, id: diva2:1646606
Anmärkning
Funding Agencies|Novo NordiskNovo Nordisk
2022-03-232022-03-232022-03-23